Unilever has added “may contain . . .” warnings on previously “nut-safe” treats such as Magnum, Cornetto and Solero.
Unilever said product safety is its top priority and people should always read the label.
Peanut allergy affects around two per cent – one in 50 – of children in the UK and has been increasing in recent decades, according to charity Allergy UK.
Allergy Therapeutics plc (LON:AGY) is a market-leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.